Evaluation of the GORE® Ascending Stent Graft

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 370 participants.

Also called NCT05800743

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 370 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05800743
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT05800743. Non-randomized; no masking; primary purpose treatment. Start 2023-11-28 (actual); primary completion 2029-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the GORE® Ascending Stent Graft
Acronym
ARISEII
Condition
Aortic Aneurysm, Thoracic
Condition
Pseudoaneurysm
Condition
Aorta; Lesion
Intervention (Device)
GORE® Ascending Stent Graft (ASG device)
Intervention (Device)
GORE® Thoracic Aortic Graft Thoracic Branch Endoprosthesis (TBE Device)
Intervention (Procedure)
Surgery
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct05800743
Content hash
6e1503a38f5a588a228f640dead0d8d9751d0844c02225ae467a2060a588467f